News by Tag: Biopharmaceuticals Market
Growth in the Pharmaceutical Industry Shifting from the Developed to the Emerging Markets
February 14, 2013
Future growth in the developed pharmaceutical markets is expected to be buffeted by a massive wave of patent expirations coupled by numerous cost constraining measures.
February 14, 2013
Future growth in the developed pharmaceutical markets is expected to be buffeted by a massive wave of patent expirations coupled by numerous cost constraining measures.
Biologics to Account for 13.5% of the Global Pharmaceutical Market in 2012
November 19, 2012
The global sales of biologics is expected to grow at 8.2 percent compared to 2011, exceeding values worth US$ 117 billion by the end of 2012.
November 19, 2012
The global sales of biologics is expected to grow at 8.2 percent compared to 2011, exceeding values worth US$ 117 billion by the end of 2012.
Global Biopharmaceutical Market to Exceed USD 166 Billion by 2017
November 1, 2012
Driven by their high potency and ability to attack targets beyond the reach of traditional small molecule drugs, the global biopharmaceutical market is expected to exceed sales worth USD 166 Billion by 2017.
November 1, 2012
Driven by their high potency and ability to attack targets beyond the reach of traditional small molecule drugs, the global biopharmaceutical market is expected to exceed sales worth USD 166 Billion by 2017.
Global Biopharmaceutical Market to Exceed USD 166 Billion by 2017
October 30, 2012
Driven by their high potency and ability to attack targets beyond the reach of traditional small molecule drugs, the global biopharmaceutical market is expected to exceed sales worth USD 166 Billion by 2017.
October 30, 2012
Driven by their high potency and ability to attack targets beyond the reach of traditional small molecule drugs, the global biopharmaceutical market is expected to exceed sales worth USD 166 Billion by 2017.
Emerging Biopharmaceutical Markets to Witness Exponential Growth
May 9, 2012
IMARC Group, one of the world's leading research and advisory firms, finds that the sales of Biopharmaceuticals in Emerging markets will nearly triple its size from US$ 5.3 Billion in 2010 to US$ 13.5 Billion in 2015
May 9, 2012
IMARC Group, one of the world's leading research and advisory firms, finds that the sales of Biopharmaceuticals in Emerging markets will nearly triple its size from US$ 5.3 Billion in 2010 to US$ 13.5 Billion in 2015